Arca
Skip to content
Tools
Tools

-perone

Butyrophenone antipsychotics and tranquillizers.

  • Drugs ending in -perone: 17
  • Approved somewhere: 12
  • With a US drug page: 7

What it means

Stem from WHO's stem book, 2024; description by Arca
Stem
-perone
Class
Butyrophenone antipsychotics and tranquillizers
Most common targets
HTR2A (8), DRD2 (8), D2-like dopamine receptor (3), SLC6A4 (1), HTR2C (1)

Drugs that carry it

Approved and clinical-stage drugs in ChEMBL whose names ending in -perone or one of its sub-stems, matched by spelling; those with a US drug page link to it.
Acts on
LumateperoneApprovedHTR2A, DRD2, SLC6A4Serotonin 2a (5-HT2a) receptor antagonist
MelperonePhase 3——
PipamperonePhase 3——
MoperonePhase 2——
DroperidolApprovedHTR2A, D2-like dopamine receptorSerotonin 2a (5-HT2a) receptor antagonist
Haloperidol decanoateApprovedHTR2A, D2-like dopamine receptorSerotonin 2a (5-HT2a) receptor antagonist
BenperidolApprovedDRD2Dopamine D2 receptor antagonist
BromperidolApprovedDRD2Dopamine D2 receptor antagonist
HaloperidolApprovedHTR2A, D2-like dopamine receptorSerotonin 2a (5-HT2a) receptor antagonist
TrifluperidolApproved——
IloperidoneApprovedDRD2, HTR2ADopamine D2 receptor antagonist
PaliperidoneApprovedDRD2, HTR2ADopamine D2 receptor antagonist
Paliperidone palmitateApprovedDRD2, HTR2ADopamine D2 receptor antagonist
RisperidoneApprovedHTR2A, HTR2C, DRD2Serotonin 2a (5-HT2a) receptor antagonist
DomperidoneApprovedDRD2Dopamine D2 receptor antagonist
RoluperidonePhase 3——
EtoperidonePhase 2——

Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.